4 Recruiting Primary Central Nervous System Lymphoma Phase 2 Clinical Trials

Active phase 2 studies for primary central nervous system lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Primary Central Nervous System Lymphoma studies

Phase 2 Studies for Primary Central Nervous System Lymphoma

🟢 Recruiting Phase2

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

📍 Brigham and Women's Hospital — Boston, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

📍 Dana Farber Cancer Institute — Boston, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase2

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

📍 Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida

View Study & Checklist ➔

🟢 Recruiting Phase2

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

📍 Memorial Sloan Kettering Cancer Center — New York, New York

View Study & Checklist ➔